meglumine has been researched along with Primary Peritonitis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kosinets, VA | 1 |
| Chekmarev, GV; Glushchenko, AV; Lukach, VN; Orlov, IuP; Zhitenev, SB | 1 |
| Goncharuk, VA; Il'chenko, FN; Kaminskiĭ, IV; Liashenko, NV; Serbul, MM | 1 |
| Barskaya, MA; Borodin, RV; Bykov, DV; Frolova, YV; Kuzmin, AI; Rodionov, VG; Varlamov, AV; Zavyalkin, VA | 1 |
| Kondratenko, GG; Kosinets, VA; Sachek, MG | 1 |
| Iarotskaia, NN; Kosinets, VA; Osochuk, SS | 1 |
| Filippov, SI; Glushchenko, AV; Lukach, VN; Maliuk, AI; Orlov, IuP; Parkhomenko, KK; Petrova, IuV; Pritykina, TV | 1 |
| Bykova, EV; Churliaev, IuA; Kan, SL; Kosovskikh, AA | 1 |
3 trial(s) available for meglumine and Primary Peritonitis
| Article | Year |
|---|---|
[The immunoregulating action of reamberine and its use in the treatment of duffuse peritonitis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cell Movement; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunity, Cellular; Lymphocytes; Male; Meglumine; Middle Aged; Peritonitis; Succinates; Treatment Outcome; Young Adult | 2013 |
[Treatment of diffuse peritonitis in children].
Topics: Adolescent; Child; Child, Preschool; Drainage; Drug Therapy, Combination; Female; Humans; Infant; Laparoscopy; Male; Meglumine; Nutritional Support; Peritonitis; Retrospective Studies; Succinates; Treatment Outcome | 2015 |
[Reamberin in combined therapy of general peritonitis].
Topics: Dose-Response Relationship, Drug; Free Radical Scavengers; Gastrointestinal Motility; Humans; Infusions, Intravenous; Intestines; Meglumine; Oxidative Stress; Peritonitis; Succinates; Treatment Outcome | 2010 |
5 other study(ies) available for meglumine and Primary Peritonitis
| Article | Year |
|---|---|
[Opportunities of correction of rheological properties of blood in intensive therapy in patients with peritonitis and acute bowel obstruction].
Topics: Acute Disease; Anti-Bacterial Agents; Blood Viscosity; Critical Care; Follow-Up Studies; Humans; Intestinal Obstruction; Meglumine; Middle Aged; Peritonitis; Succinates; Treatment Outcome | 2013 |
[Prophylaxis and correction of inflammatory complications in peritonitis, depending on severity of enteral insufficiency].
Topics: Adult; Endotoxins; Enterosorption; Female; Humans; Inflammation; Interleukin-6; Intubation, Gastrointestinal; Male; Meglumine; Middle Aged; Peritonitis; Severity of Illness Index; Silicates; Succinates; Tumor Necrosis Factor-alpha | 2015 |
[Effect of reamberin on the lipid spectrum of the liver mitochondria in experimental widespread purulent peritonitis].
Topics: Animals; Cholesterol; Glycerophosphates; Lysophospholipids; Meglumine; Mitochondria, Liver; Mitochondrial Membranes; Peritonitis; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Rabbits; Sphingomyelins; Succinates | 2010 |
[The efficacy and safety of the reamberin balanced solution for the acute intestinal obstruction and peritonitis treatment].
Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Intestinal Obstruction; Male; Meglumine; Peritonitis; Succinates | 2012 |
[Correction of infringements of microcirculation at a widespread peritonitis].
Topics: Female; Humans; Infusions, Intravenous; Laser-Doppler Flowmetry; Male; Meglumine; Microcirculation; Middle Aged; Peritoneum; Peritonitis; Pharmaceutical Solutions; Succinates; Suppuration; Treatment Outcome | 2012 |